Table 2.
Comparison of Postintervention Patient Encounter Results across Department/Specialty*
| 2022 (Quarter 2–4) | 2023 (Quarter 1–3) | ||
|---|---|---|---|
| n = 214 | n = 226 | P values, Q1–3, 2023 | |
| Encounters,† n (%) | |||
| Outpatient specialties | 50 (23.4) | 41 (18.8) | n/a |
| Inpatient specialties | 12 (5.6) | 19 (8.4) | |
| ED | 42 (19.6) | 40 (17.7) | |
| Hospital medicine | 69 (32.2) | 72 (31.9) | |
| ICU | 41 (19.2) | 54 (23.9) | |
| AVS communication,‡, n (%) | |||
| Outpatient specialties | n/a | n/a | |
| Inpatient specialties | 1 (8.3) | 11 (57.9) | 0.003 |
| ED | 23 (54.8) | 33 (82.5) | |
| Hospital medicine | 18 (27.3) | 57 (85.1) | |
| ICU | 8 (33.3) | 20 (76.9) | |
| DC summary communication, n (%) | |||
| Outpatient specialties | n/a | n/a | |
| Inpatient specialties | 0 (0.0) | 7 (36.8) | 0.5 |
| ED | 19 (45.2) | 21 (52.5) | |
| Hospital medicine | 19 (28.8) | 39 (58.2) | |
| ICU | 13 (54.2) | 20 (76.9) | |
| TFT completion, n (%) | |||
| Outpatient specialties | 6 (12.0) | 8 (19.5) | <0.001 |
| Inpatient specialties | 0 (0.0) | 4 (21.1) | |
| ED | n/a | n/a | |
| Hospital medicine | 3 (4.3) | 9 (12.5) | |
| ICU | 24 (58.5) | 38 (70.4) | |
Data are expressed as number (%); n represents the total number of patient encounters, excluding encounters for patients who were deceased before the time thyroid testing was indicated or as otherwise noted.
Department or specialty caring for the patient at the time thyroid testing was due (if inpatient), at the time of DC (if patient was discharged before the time that testing was indicated), or responsible for ordering of contrast study/procedure done as an outpatient.
Encounters within each respective department/specialty out of the total number of patient encounters, excluding encounters for patients who were deceased before the time thyroid testing was indicated.
For AVS communication, DC summary communication, and TFTs completed, the denominator is the total number of encounters within the respective department/specialty, excluding encounters for patients who had TFTs completed that were normal before the time of DC and those who were deceased before the time that thyroid testing was indicated.
n/a, not applicable.